Evaluating the Correlation Between Popularity and Quality: An Analysis of CAR-T Therapy Videos on Chinese Short-Video Platforms - Top-Institutions - MDSpire

Evaluating the Correlation Between Popularity and Quality: An Analysis of CAR-T Therapy Videos on Chinese Short-Video Platforms

  • By

  • Simeng Gao

  • Jingru Han

  • Yan Zhang

  • Jie Liao

  • Jiayi Yang

  • Yang Zhao

  • Linhao Xie

  • Min Su

  • Jianfu Zhao

  • March 1, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    University of Pennsylvania
    University of Pennsylvania

    Philadelphia, PA

    Key Differentiators

    • Hematology
    • Oncology
    • Immunotherapy

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Hematology
    • Oncology
    • Cell Therapy

  • #3

    Fred Hutchinson Cancer Center
    Fred Hutchinson Cancer Center

    Seattle, WA

    Key Differentiators

    • Hematology
    • Immunotherapy
    • Cellular Therapy

  • #4

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Oncology
    • Hematology
    • Cell Therapy

  • #5

    National Cancer Institute (NCI)
    National Cancer Institute (NCI)

    Bethesda, MD

    Key Differentiators

    • Cancer Research
    • Immunotherapy
    • Hematology

Original Source(s)

Evaluating the Correlation Between Popularity and Quality: An Analysis of CAR-T Therapy Videos on Chinese Short-Video Platforms

  • by Simeng Gao, Jingru Han, Yan Zhang, Jie Liao, Jiayi Yang, Yang Zhao, Linhao Xie, Min Su, Jianfu Zhao

  • March 1, 2026

Related Content

Treatment Intensity in the Frontline Setting for Transplant-Ineligible Patients With Multiple Myeloma

The management of newly diagnosed transplant-ineligible multiple myeloma remains challenging, in part due to the complexity of treatment decisions for frail patients. Recent subgroup analyses provide insight into whether quadruplet therapy may offer advantages over triplet therapy in this population.

Infection incidence, timing, and predictors in newly diagnosed multiple myeloma: a real-world retrospective cohort study

Delays in Hematology Consultations and Non-Hematology Referrals in Blood Cancer Diagnosis: Insights from a Comprehensive National Survey in Australia